A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response

Clinical trial NCT02214381 · COMPLETED

Trial details

NCT number: NCT02214381
Sponsor: Women's Cancer Study Group GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Primary Breast Cancer

Start date: 2014-07-01
Primary completion: 2015-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.